Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Immunol Rev. 2013 Jul;254(1):114–142. doi: 10.1111/imr.12063

Fig. 3. LPS and immune activation in HIV-HBV co-infection.

Fig. 3

Plasma levels of LPS and soluble (s)CD14 (pg/ml) in untreated HIV-HBV co-infection (blue, n=54), HBV mono-infection (red, n=52), and uninfected controls (black, n=10). Individual dots represent a single patient.